Equities

China Resources Pharmaceutical Group Ltd

China Resources Pharmaceutical Group Ltd

Actions
  • Price (EUR)0.66
  • Today's Change-0.01 / -1.49%
  • Shares traded0.00
  • 1 Year change+17.86%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments59,26646,52247,067
Total Receivables, Net75,57267,87262,772
Total Inventory31,87526,54724,190
Prepaid expenses4,7974,9533,507
Other current assets, total7,0576,3666,367
Total current assets178,568152,259143,903
Property, plant & equipment, net25,37622,09220,804
Goodwill, net21,45420,40920,290
Intangibles, net8,0407,5927,441
Long term investments10,6488,1147,927
Note receivable - long term7901,018--
Other long term assets1212.581,100
Total assets246,770215,534202,531
LIABILITIES
Accounts payable54,58148,85342,680
Accrued expenses4,2313,9633,169
Notes payable/short-term debt2,9919,8050
Current portion long-term debt/capital leases46,22436,79939,465
Other current liabilities, total26,20622,34929,837
Total current liabilities134,233121,770115,151
Total long term debt15,9379,8126,611
Total debt65,15256,41646,076
Deferred income tax1,7181,5871,601
Minority interest47,01537,00035,854
Other liabilities, total1,9071,8071,774
Total liabilities200,811171,977160,991
SHAREHOLDERS EQUITY
Common stock24,63024,63022,197
Additional paid-in capital------
Retained earnings (accumulated deficit)23,31420,83917,366
Treasury stock - common------
Unrealized gain (loss)606491410
Other equity, total(2591)(2404)1,568
Total equity45,96043,55741,540
Total liabilities & shareholders' equity246,770215,534202,531
Total common shares outstanding6,2836,2836,283
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.